Background: The distal splenorenal shunt is an effective procedure for the treatment of portal hypertension in children. However, there has been no report about laparoscopic distal splenorenal shunt in the treatment of portal hypertension in children.
Introduction
With the improvements of laparoscopic surgery, the laparoscopic techniques were used for the treatment of portal hypertension in children, such as laparoscopic splenectomy with esophagogastric devascularization and laparoscopic splenic vessel ligation. [1] [2] [3] However, laparoscopic splenectomy and splenic vessel ligation are only used to treat the hypersplenism caused by portal hypertension, and laparoscopic esophagogastric devascularization is used to control the variceal bleeding. Splenectomy can effectively relieve the hypersplenism, but it is associated with perioperative and postoperative complications. [4] The long-term result of laparoscopic splenic vessel ligation is uncertain. The distal splenorenal shunt (Warren shunt) is an effective procedure for the treatment of portal hypertension in children [5, 6] ; it preserves the spleen, avoids the overwhelming postsplenectomy sepsis, reduces the splenic vein pressure and keeps the hepatopetal blood flow of portal vein. Long-term patency rates greater than 90% have been reported. However, there has been no report about laparoscopic distal splenorenal shunt in the treatment of portal hypertension in children. In this study, we reported our experience in laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension.
Patients and methods
Between December 2015 and August 2016, 4 children (age 2.7-7.8 years, 3 boys and 1 girl) with hematemesis and melaena were admitted to our hospital. The abdominal sonography, computed tomography (CT), blood routine, and biochemistry were performed preoperatively. The abdominal ultrasound and CT showed portal hypertension, liver fibrosis, and splenomegaly. The liver function was normal.
Surgical indication included absence of previous surgical history; portal hypertension caused by liver cirrhosis and fibrosis, or extrahepatic portal hypertension which was unsuitable for Rex shunt; the diameter of adrenal vein was greater than 5 mm; no contraindication of laparoscopic surgery.
Surgical procedure
The patients were placed in supine position. After induction of general anesthesia, a transumbilical 2 to 3 cm superficial longitudinal incision was made. The small intestine was exteriorized through the umbilical incision, and a catheter was inserted into a branch of superior mesenteric vein to measure the portal pressure and perform the mesenteric angiography. The selective mesenteric angiography was used to identify the morphology of portal venous system. A 13-mm port was placed in the umbilical incision and other three 5-mm ports were placed as shown in Fig. 1 . The pancreas and splenic hilum were exposed through dissecting the gastrocolic and splenogastric ligament and suspension of posterior gastric wall. The splenic artery was dissected along the upper border of pancreas, and was clipped using a vascular clamp (Fig. 2) . The splenic vein was dissected off the posterior and inferior borders of pancreas, and was ligated using a hem-o-lok at the junction of splenic and inferior mesenteric vein (Fig. 3A) . The proximal end of splenic vein was clipped using a vascular clamp (Fig. 3B) . The left renal and adrenal veins were exposed by dissecting the descending colon which was retracted to the right by the assistant (Fig. 4A ). The adrenal vein was clipped at the confluence of adrenal and renal vein (Fig. 4B ). The adrenal vein was ligated and divided 1 cm from the renal vein, and the lumen of splenic and adrenal vein was irrigated by heparinized saline through a percutaneous tube to avoid thrombosis (Fig. 5 ). The adrenal vein was anastomosed end-to-end with the distal end of the splenic vein (Fig. 6 ). The vascular anastomosis was performed using 7/0 Prolene suture discontinuously. Under laparoscope, the anastomotic stoma was amplified, which helped to expose the vascular end and perform the vascular anastomosis. After anastomosis, the vascular clamps of splenic and renal vein were removed, and the vascular clamp of splenic artery was removed after confirming that there was no anastomotic bleeding. The patency of the bypass vein was checked and the superior mesenteric vein pressure was measured.
All the children were followed up at postoperative 1, 3, 6, 12 months and every 6 months thereafter. During the follow-up, abdominal ultrasound, CT, upper gastrointestinal imaging (UGI), and laboratory tests (routine blood test, liver function, coagulation function, and blood ammonia) were conducted at each visit. The spleen size and patency of bypass vein were assessed with ultrasound and CT.
Ethical statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All infants' guardians signed their informed consent before their inclusion in the study.
Results
The laparoscopic distal splenoadrenal shunt was successfully performed in all 4 patients. No conversion was required. The liver fibrosis was diagnosed by postoperative liver pathology. The operative time was between 180 and 360 minutes (mean: 270 minutes). The blood loss was minimal without necessity for blood transfusion. The postoperative hospital stay was 6 to 13 days (mean: 8.5 days). The anastomotic diameter was 0.5 to 1 cm (mean: 0.73 cm). The duration of follow-up was 1 to 9 months (mean: 3.8 months). The levels of red blood cell, platelet and white blood cell returned to normal postoperatively. The liver function was normal after the surgeries (the average of alanine aminotransferase: preoperative: 22.3 U/L, postoperative: 28.5 U/ L). The portal pressure and size of spleen was reduced after surgery (Table 1 ). There was no rebleeding. The patency of bypass vein was shown by postoperative sonography and CT (Fig. 7) .
Discussion
Liver fibrosis is the common endpoint of liver disease, which is not a rare disease in children. Currently, there is no effective therapy for liver fibrosis. Liver fibrosis is one of the main causes of intrahepatic portal hypertension in children. [7] Variceal hemorrhage caused by portal hypertension is an important complication of liver fibrosis in children. Management of variceal hemorrhage secondary to portal hypertension includes medical interventions, endoscopic variceal ligation (EVL) and sclerotherapy, devascularization, and shunting procedures. About 15% of patients suffered from recurrence of bleeding after medical therapy. The varices disappeared in only 11.8% children undergoing the sclerotherapy. [8] Rebleeding rate of 27.8% and esophageal varies recurrence rate of 44.4% have been reported in children undergoing EVL. [9] Splenectomy can effectively relieve the hypersplenism. However, children undergoing splenectomy are susceptible to overwhelming postsplenectomy infection (OPSI) and portal venous thrombosis.
[10] The incidence of portal vein thrombosis varied from 1.6% to 15% after splenectomy. [11, 12] In addition, Ikeda et al [13] observed a higher incidence of portal vein thrombosis after laparoscopy than after laparotomy, which might be related with the effects of pneumoperitoneum and the laparoscopic stapling technique for vessels. The shunting procedures include selective and nonselective shunt. However, the nonselective shunt (such as mesocaval shunt and portaocaval shunt) diverts a significant amount of portal venous blood from its normal liver metabolism, predisposing the development of hepatic encephalopathy. Fifty percent rebleeding rate and 53% mortality were reported in children with intrahepatic portal hypertension undergoing nonselective shunt. [14] Warren shunt is a selective shunt, which reduces the splenic pressure and alleviates the hypersplenism through the distal splenorenal bypass. The venous collaterals around the stomach and lower esophagus are decompressed, which reduces the risk of hemorrhage. [15] In addition, the Warren shunt preserves the hepatopetal blood flow, which diminishes the risks of postoperative encephalopathy and liver failure. Long-term patency rates >90% have been reported.
Laparoscopic splenic vessel ligation and splenectomy were used to treat hypersplenism secondary to portal hypertension. [1] [2] [3] Laparoscopic splenectomy was first reported in 1991. The advantages of the laparoscopic approach over open surgery include a shorter hospital stay, decreased blood loss, faster recovery, and better cosmesis. [16] However, a higher incidence of portal vein thrombosis after laparoscopy than after laparotomy has been reported. [13] Laparoscopic splenic vessels ligation is a feasible treatment for hypersplenism, which has the advantages of laparoscopic surgery. [2] However, this report has a short-term follow-up and fewer cases, and the long-term outcome need to be further studied. Splenectomy and splenic vessel ligation might reduce the portal pressure, which were mainly used to treat the hypersplenism and splenomegaly. In this study, laparoscopic distal splenoadrenal shunt was used to the treatment of portal hypertension in children, it has the following advantages: clear visual field, reduced tissue trauma, decreased postoperative pain, better cosmetic results, and accelerated patient recovery. However, the operative time of laparoscopic surgery is longer than open surgery; this might be related with the lack of experience and had a learning curve as other laparoscopic procedures. In this study, the portal pressure and splenic size was reduced after surgery, which suggested this procedure is a feasible and effective treatment for portal hypertension. However, this study is a preliminary report about laparoscopic splenoadrenal shunt. Further studies with a larger sample size Figure 6 . The distal end of splenic vein was anastomosed with the adrenal vein (A: before surgery; B: after surgery). Table 1 The pre-and postoperative parameters of the patients. and longer follow-up duration are needed to improve the surgical technique and verify our initial results. The successful operation was based on the operators' extensive experience for laparoscopic surgery and the technique of vascular anastomosis. To date, the laparoscopic vascular anastomosis has been rarely reported in children. The challenges of laparoscopic splenoadrenal shunt include: Owing to the retroperitoneal location of splenic and renal vein, the exposure of the surgical field is difficult. We have reported the suspension method and dissection of pancreas in our previous literature. [17, 18] In this study, stomach-and pancreas-suspension methods were used to expose the surgical field. The port C (the camera port) forms a triangle with the port A and B, which facilitates triangulation (Fig. 1) . In this study, the usage of the vascular clamps and right angle clamp make it possible to do the laparoscopic vascular anastomosis. In this study, the splenic vein was anastomosed with the adrenal vein, which facilitates the blockage of renal vein and avoids the dissection of renal vein. Previous studies have suggested that the splenoadrenal shunt is an effective treatment for children with portal hypertension. [19, 20] The splenic artery was clipped before dissection of the splenic vein, and the clamp of the splenic artery was removed after vascular anastomosis, which reduced the bleeding during the operation.
Conclusion
In conclusion, our report suggests that laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children is feasible and safe in experienced centers.
